Peeling Back The Layers: Exploring Travere Therapeutics Through Analyst Insights
Peeling Back The Layers: Exploring Travere Therapeutics Through Analyst Insights
揭开层面：通过分析师见解探索 Travere 疗法
Travere Therapeutics (NASDAQ:TVTX) has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
在过去的三个月中，有6位分析师对Travere Therapeutics（纳斯达克股票代码：TVTX）进行了分析，揭示了从看涨到看跌的不同观点。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中，您将找到他们最近的评级摘要，揭示了过去30天中情绪的变化，并将其与前几个月进行了比较。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $13.33, with a high estimate of $20.00 and a low estimate of $9.00. This upward trend is apparent, with the current average reflecting a 9.26% increase from the previous average price target of $12.20.
分析师对12个月目标股价的评估提供了更多见解，显示平均目标价为13.33美元，最高估计为20.00美元，低估值为9.00美元。这种上升趋势显而易见，当前的平均价格较之前的平均目标价12.20美元上涨了9.26％。
Deciphering Analyst Ratings: An In...
解密分析师...
登录免费看全文
登录/注册